GTS Securities’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

GTS Securities’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$996K	Buy	+19,027	New	+$968K	0.04%	400
2025 Q4	–	Sell	-38,376	Closed	-$1.49M	–	1733
2025 Q3	$1.49M	Sell	38,376 -28,251	-42%	-$971K	0.06%	285
2025 Q2	$2M	Buy	66,627 +41,739	+168%	+$1.19M	0.09%	178
2025 Q1	$710K	Sell	24,888 -16,983	-41%	-$537K	0.03%	534
2024 Q4	$1.38M	Buy	+41,871	New	+$1.58M	0.07%	228
2024 Q2	–	Sell	-9,154	Closed	-$327K	–	4269
2024 Q1	$327K	Sell	9,154 -8,738	-49%	-$303K	﹤0.01%	2922
2023 Q4	$589K	Sell	17,892 -272	-1%	-$7.3K	﹤0.01%	2652
2023 Q3	$494K	Buy	18,164 +7,712	+74%	+$232K	﹤0.01%	2639
2023 Q2	$330K	Buy	+10,452	New	+$325K	0.01%	837

Other funds holding SBIO

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.27B AUM 25.8% 1-Year Est. Return

GTS Securities's SBIO Position: Q1 2026 in Review

GTS Securities opened a new position in ALPS Medical Breakthroughs ETF (SBIO) in Q1 2026: 19,027 shares worth $996K. The stake represents 0.04% of the portfolio and ranks #400 among its holdings. This is a return to the name: GTS Securities previously reported a position in SBIO as recently as Q3 2025.

GTS Securities first reported a position in SBIO in Q2 2023 and has held it in 9 quarters since. The position peaked at $2M in Q2 2025. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

GTS Securities held 19,027 shares of ALPS Medical Breakthroughs ETF worth $996K as of Q1 2026.
ALPS Medical Breakthroughs ETF was a new GTS Securities position in Q1 2026.
ALPS Medical Breakthroughs ETF made up 0.04% of GTS Securities's portfolio in Q1 2026, its #400 holding.
GTS Securities first reported a position in ALPS Medical Breakthroughs ETF in Q2 2023 and has held it in 9 quarters since.
GTS Securities's ALPS Medical Breakthroughs ETF position peaked at $2M in Q2 2025.
59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.